Constitutive activation of c-Met signaling has been reported to promote melanoma metastasis in mice [15,16], while inhibition of c-Met signaling with a specific small molecule tyrosine kinase inhibitor reduced growth and metastasis of experimental human melanoma [17,18]. The gene discussed is MET; the disease is melanoma.